Skip to Content

VICC toll-free number 1-877-936-8422


The ITR is collaborating with clinical and laboratory investigators to guide the initiation and completion of pre-clinical research and Phase I and Phase II correlative studies in:

  • Breast Cancer
  • Colon Cancer
  • Graft versus host disease
  • Head and neck cancer
  • Lung Cancer
  • Leukemia
  • Lymphoma
  • Melanoma

In particular, we are interested in the following:

  • Elucidating mechanisms of action of cancer therapies in both preclinical models and primary human tumors.
  • Predicting sensitivity and resistance to novel targeted-molecular therapeutics.
  • Developing new molecular classifications of cancers.

The ITR also helps to design and execute customized translational research projects with clinical and laboratory investigators.

We welcome new projects in any tumor type!

Past and present collaborators:

  • Carlos Arteaga, MD
  • Dan Beauchamp, MD
  • Jordan Berlin, MD
  • Clinton Carroll, MD
  • Christine Chung, MD
  • Daniel Cohen, MD, PhD
  • Utpal DavĂ©, MD
  • Brian Engelhardt, MD
  • Madan Jagasia, MD
  • Douglas Johnson, MD
  • Eric Liu, MD
  • Christine Lovly, MD, PhD
  • Charles Manning, PhD
  • Julie Means-Powell, MD
  • Ryoma Ohi, PhD
  • William Pao, MD, PhD
  • Jennifer Pietenpol, PhD
  • Vito Quaranta, MD
  • Nishitha Reddy, MD
  • Brent Rexer, MD, PhD
  • Ann Richmond, PhD
  • Chanjuan Shi, MD, PhD
  • Jeff Sosman, MD
  • Stephen Strickland, MD, MSCI
  • Neeta Venepalli, MD
  • Alissa Weaver, MD, PhD
  • Wendell Yarbrough, MD, FACS
  • Zhongming Zhao, PhD